Direct coupling of the cell cycle and cell death machinery by E2F-Reference-Cited by-同舟云学术

Direct coupling of the cell cycle and cell death machinery by E2F

Published:2002-10-21 Issue:11 Volume:4 Page:859-864
ISSN:1465-7392
Container-title:Nature Cell Biology
language:en
Short-container-title:Nat Cell Biol

Author:

Nahle Zaher,Polakoff Julia,Davuluri Ramana V.,McCurrach Mila E.,Jacobson Matthew D.,Narita Masashi,Zhang Michael Q.,Lazebnik Yuri,Bar-Sagi Dafna,Lowe Scott W.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology

Link

http://www.nature.com/articles/ncb868.pdf

Reference36 articles.

1. Evan, G. I. & Vousden, K. H. Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342–348 (2001).

2. Sherr, C. J. The INK4a/ARF network in tumour suppression. Nature Rev. Mol. Cell Biol. 2, 731–737 (2001).

3. Trimarchi, J. M. & Lees, J. A. Sibling rivalry in the E2F family. Nature Rev. Mol. Cell Biol. 3, 11–20 (2002).

4. Tolbert, D., Lu, X., Yin, C., Tantama, M. & Van Dyke, T. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumour suppression in vivo. Mol. Cell. Biol. 22, 370–377 (2002).

5. Russell, J. L. et al. ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol. Cell. Biol. 22, 1360–1368 (2002).

Cited by 375 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular communication network 1 promotes CASP2 mRNA expression but suppresses its protein translation in esophageal adenocarcinoma;Journal of Cell Communication and Signaling;2024-07-17

2. DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11;Oncogene;2024-01-05

3. PP2A and its adapter protein IER5 induce the DNA-binding ability and target gene expression of E2F1 via dephosphorylation at serine 375;Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms;2023-09

4. Inhibition of miR-221-3p promotes axonal regeneration and repair of primary sensory neurons via regulating p27 expression;NeuroReport;2023-04-28

5. A proof-of-concept study poised to remodel the drug development process;Frontiers in Medical Technology;2022-12-16